Urticarial Vasculitis (Hypo-C) Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Urticarial Vasculitis (Hypo-C)
Urticarial vasculitis hypocomplementemia (UVH) is a rare autoimmune disorder causing persistent, painful hives and systemic inflammation. Managing this condition often requires costly, ongoing medications. TheDrugClub understands these challenges, offering a straightforward way for members to access significant discounts on the prescriptions needed to manage UVH, helping ease the financial burden of treatment.
Urticarial vasculitis hypocomplementemia (UVH), sometimes referred to as urticarial vasculitis hypo C, is a less common form of vasculitis, an inflammatory condition affecting blood vessels. Unlike typical hives that disappear within 24 hours, the characteristic red, itchy, and often painful welts of UVH persist for more than 24-48 hours and can leave bruising or discoloration as they fade. The "hypocomplementemia" aspect refers to abnormally low levels of complement proteins in the blood, which are part of the immune system. This indicates a more systemic inflammatory process, suggesting that the condition may affect internal organs like the kidneys, joints, lungs, or gastrointestinal tract, making careful diagnosis and management crucial.
Treating UVH typically involves a multi-pronged approach tailored to the severity of the condition and specific symptoms. Initial treatments often include high-dose antihistamines to help manage the itching. For more severe skin lesions or systemic involvement, corticosteroids like prednisone are frequently prescribed to reduce inflammation. If corticosteroids aren't effective or long-term use is not advisable, other immunosuppressive medications may be used. These can include dapsone, colchicine, hydroxychloroquine, methotrexate, azathioprine, or mycophenolate mofetil. In cases that are resistant to these therapies, biologics such as omalizumab (Xolair) might be considered. The ongoing nature of this condition often means these medications are needed long-term, leading to substantial out-of-pocket costs.
This is where TheDrugClub steps in to support individuals and families managing UVH. Our prescription savings membership program is designed to make essential medications more affordable. With a Drug Club membership, members gain access to discounted prices on thousands of FDA-approved
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.